Placebo-Controlled Onset-of-Action Study of Flurbiprofen Utilizing the Double-Stopwatch Method
Status:
Completed
Trial end date:
2014-04-01
Target enrollment:
Participant gender:
Summary
The study's purpose is to demonstrate the onset of action, i.e., time to meaningful pain
relief in patients with pharyngitis, of flurbiprofen 8.75 mg lozenge using the
Double-Stopwatch Method (DSW).